GPR119 agonists for the treatment of type 2 diabetes: an updated patent review (2014-present)
{{output}}
Introduction: Type 2 diabetes is a rapid-growing complex chronic metabolic disease characterized by hyperglycemia due to lessened insulin secretion, insulin resistance and hepatic glucose overproduction. GPR119 is a class A of G protein-coupled receptor, expre... ...